TY - JOUR
T1 - The role of nitric oxide in the pathophysiology of intimal hyperplasia
AU - Ahanchi, Sadaf S.
AU - Tsihlis, Nick D.
AU - Kibbe, Melina R.
PY - 2007/6
Y1 - 2007/6
N2 - Since its discovery, nitric oxide (NO) has emerged as a biologically important molecule and was even named Molecule of the Year by Science magazine in 1992. Specific to our interests, NO has been implicated in the regulation of vascular pathology. This review begins with a summary of the molecular biology of NO, from its discovery to the mechanisms of endogenous production. Next, we turn our attention to describing the arterial injury response of neointimal hyperplasia, and we review the role of NO in the pathophysiology of neointimal hyperplasia. Finally, we review the literature regarding NO-based therapies. This includes the development of inhalational-based NO therapies, systemically administered L-arginine and NO donors, NO synthase gene therapy, locally applied NO donors, and NO-releasing prosthetic materials. By reviewing the current literature, we emphasize the tremendous clinical potential that NO-based therapies can have on the development of neointimal hyperplasia.
AB - Since its discovery, nitric oxide (NO) has emerged as a biologically important molecule and was even named Molecule of the Year by Science magazine in 1992. Specific to our interests, NO has been implicated in the regulation of vascular pathology. This review begins with a summary of the molecular biology of NO, from its discovery to the mechanisms of endogenous production. Next, we turn our attention to describing the arterial injury response of neointimal hyperplasia, and we review the role of NO in the pathophysiology of neointimal hyperplasia. Finally, we review the literature regarding NO-based therapies. This includes the development of inhalational-based NO therapies, systemically administered L-arginine and NO donors, NO synthase gene therapy, locally applied NO donors, and NO-releasing prosthetic materials. By reviewing the current literature, we emphasize the tremendous clinical potential that NO-based therapies can have on the development of neointimal hyperplasia.
UR - http://www.scopus.com/inward/record.url?scp=34249325882&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=34249325882&partnerID=8YFLogxK
U2 - 10.1016/j.jvs.2007.02.027
DO - 10.1016/j.jvs.2007.02.027
M3 - Article
C2 - 17544026
AN - SCOPUS:34249325882
SN - 0741-5214
VL - 45
SP - A64-A73
JO - Journal of Vascular Surgery
JF - Journal of Vascular Surgery
IS - 6 SUPPL.
ER -